Global POC Infectious Diseases Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 90227
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Medical Devices
Buy @ $3500

The POC Infectious Diseases market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global POC Infectious Diseases size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global POC Infectious Diseases market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

POC Infectious Diseases market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Flu

Adenovirus

Malaria

Streptococcal Bacteremia

Tuberculosis (TB)

Occult Blood

HIV

Market segment by Application, can be divided into

Hospital& Clinics

Clinical Diagnostic Laboratories

Homecare Settings

Market segment by players, this report covers

Abbott

Meridian Bioscience

Orasure Technologies

Trinity Biotech

Beckman Coulter/ Danaher

Becton Dickinson

Biomerieux

Bio-Rad

Cepheid

Diamedix

Diasorin

Eiken Chemical

Enzo Biochem

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe POC Infectious Diseases product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of POC Infectious Diseases, with revenue, gross margin and global market share of POC Infectious Diseases from 2019 to 2021.

Chapter 3, the POC Infectious Diseases competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and POC Infectious Diseases market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe POC Infectious Diseases research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of POC Infectious Diseases

1.2 Classification of POC Infectious Diseases by Type

1.2.1 Overview: Global POC Infectious Diseases Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global POC Infectious Diseases Revenue Market Share by Type in 2020

1.2.3 Flu

1.2.4 Adenovirus

1.2.5 Malaria

1.2.6 Streptococcal Bacteremia

1.2.7 Tuberculosis (TB)

1.2.8 Occult Blood

1.2.9 HIV

1.3 Global POC Infectious Diseases Market by Application

1.3.1 Overview: Global POC Infectious Diseases Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospital& Clinics

1.3.3 Clinical Diagnostic Laboratories

1.3.4 Homecare Settings

1.4 Global POC Infectious Diseases Market Size & Forecast

1.5 Global POC Infectious Diseases Market Size and Forecast by Region

1.5.1 Global POC Infectious Diseases Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global POC Infectious Diseases Market Size by Region, (2016-2021)

1.5.3 North America POC Infectious Diseases Market Size and Prospect (2016-2026)

1.5.4 Europe POC Infectious Diseases Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific POC Infectious Diseases Market Size and Prospect (2016-2026)

1.5.6 South America POC Infectious Diseases Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa POC Infectious Diseases Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 POC Infectious Diseases Market Drivers

1.6.2 POC Infectious Diseases Market Restraints

1.6.3 POC Infectious Diseases Trends Analysis

2 Company Profiles

2.1 Abbott

2.1.1 Abbott Details

2.1.2 Abbott Major Business

2.1.3 Abbott POC Infectious Diseases Product and Solutions

2.1.4 Abbott POC Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Abbott Recent Developments and Future Plans

2.2 Meridian Bioscience

2.2.1 Meridian Bioscience Details

2.2.2 Meridian Bioscience Major Business

2.2.3 Meridian Bioscience POC Infectious Diseases Product and Solutions

2.2.4 Meridian Bioscience POC Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Meridian Bioscience Recent Developments and Future Plans

2.3 Orasure Technologies

2.3.1 Orasure Technologies Details

2.3.2 Orasure Technologies Major Business

2.3.3 Orasure Technologies POC Infectious Diseases Product and Solutions

2.3.4 Orasure Technologies POC Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Orasure Technologies Recent Developments and Future Plans

2.4 Trinity Biotech

2.4.1 Trinity Biotech Details

2.4.2 Trinity Biotech Major Business

2.4.3 Trinity Biotech POC Infectious Diseases Product and Solutions

2.4.4 Trinity Biotech POC Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Trinity Biotech Recent Developments and Future Plans

2.5 Beckman Coulter/ Danaher

2.5.1 Beckman Coulter/ Danaher Details

2.5.2 Beckman Coulter/ Danaher Major Business

2.5.3 Beckman Coulter/ Danaher POC Infectious Diseases Product and Solutions

2.5.4 Beckman Coulter/ Danaher POC Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Beckman Coulter/ Danaher Recent Developments and Future Plans

2.6 Becton Dickinson

2.6.1 Becton Dickinson Details

2.6.2 Becton Dickinson Major Business

2.6.3 Becton Dickinson POC Infectious Diseases Product and Solutions

2.6.4 Becton Dickinson POC Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Becton Dickinson Recent Developments and Future Plans

2.7 Biomerieux

2.7.1 Biomerieux Details

2.7.2 Biomerieux Major Business

2.7.3 Biomerieux POC Infectious Diseases Product and Solutions

2.7.4 Biomerieux POC Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Biomerieux Recent Developments and Future Plans

2.8 Bio-Rad

2.8.1 Bio-Rad Details

2.8.2 Bio-Rad Major Business

2.8.3 Bio-Rad POC Infectious Diseases Product and Solutions

2.8.4 Bio-Rad POC Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Bio-Rad Recent Developments and Future Plans

2.9 Cepheid

2.9.1 Cepheid Details

2.9.2 Cepheid Major Business

2.9.3 Cepheid POC Infectious Diseases Product and Solutions

2.9.4 Cepheid POC Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Cepheid Recent Developments and Future Plans

2.10 Diamedix

2.10.1 Diamedix Details

2.10.2 Diamedix Major Business

2.10.3 Diamedix POC Infectious Diseases Product and Solutions

2.10.4 Diamedix POC Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Diamedix Recent Developments and Future Plans

2.11 Diasorin

2.11.1 Diasorin Details

2.11.2 Diasorin Major Business

2.11.3 Diasorin POC Infectious Diseases Product and Solutions

2.11.4 Diasorin POC Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Diasorin Recent Developments and Future Plans

2.12 Eiken Chemical

2.12.1 Eiken Chemical Details

2.12.2 Eiken Chemical Major Business

2.12.3 Eiken Chemical POC Infectious Diseases Product and Solutions

2.12.4 Eiken Chemical POC Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Eiken Chemical Recent Developments and Future Plans

2.13 Enzo Biochem

2.13.1 Enzo Biochem Details

2.13.2 Enzo Biochem Major Business

2.13.3 Enzo Biochem POC Infectious Diseases Product and Solutions

2.13.4 Enzo Biochem POC Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Enzo Biochem Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global POC Infectious Diseases Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 POC Infectious Diseases Players Market Share

3.2.2 Top 10 POC Infectious Diseases Players Market Share

3.2.3 Market Competition Trend

3.3 POC Infectious Diseases Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global POC Infectious Diseases Revenue and Market Share by Type (2016-2021)

4.2 Global POC Infectious Diseases Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global POC Infectious Diseases Revenue Market Share by Application (2016-2021)

5.2 POC Infectious Diseases Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America POC Infectious Diseases Revenue by Type (2016-2026)

6.2 North America POC Infectious Diseases Revenue by Application (2016-2026)

6.3 North America POC Infectious Diseases Market Size by Country

6.3.1 North America POC Infectious Diseases Revenue by Country (2016-2026)

6.3.2 United States POC Infectious Diseases Market Size and Forecast (2016-2026)

6.3.3 Canada POC Infectious Diseases Market Size and Forecast (2016-2026)

6.3.4 Mexico POC Infectious Diseases Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe POC Infectious Diseases Revenue by Type (2016-2026)

7.2 Europe POC Infectious Diseases Revenue by Application (2016-2026)

7.3 Europe POC Infectious Diseases Market Size by Country

7.3.1 Europe POC Infectious Diseases Revenue by Country (2016-2026)

7.3.2 Germany POC Infectious Diseases Market Size and Forecast (2016-2026)

7.3.3 France POC Infectious Diseases Market Size and Forecast (2016-2026)

7.3.4 United Kingdom POC Infectious Diseases Market Size and Forecast (2016-2026)

7.3.5 Russia POC Infectious Diseases Market Size and Forecast (2016-2026)

7.3.6 Italy POC Infectious Diseases Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific POC Infectious Diseases Revenue by Type (2016-2026)

8.2 Asia-Pacific POC Infectious Diseases Revenue by Application (2016-2026)

8.3 Asia-Pacific POC Infectious Diseases Market Size by Region

8.3.1 Asia-Pacific POC Infectious Diseases Revenue by Region (2016-2026)

8.3.2 China POC Infectious Diseases Market Size and Forecast (2016-2026)

8.3.3 Japan POC Infectious Diseases Market Size and Forecast (2016-2026)

8.3.4 South Korea POC Infectious Diseases Market Size and Forecast (2016-2026)

8.3.5 India POC Infectious Diseases Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia POC Infectious Diseases Market Size and Forecast (2016-2026)

8.3.7 Australia POC Infectious Diseases Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America POC Infectious Diseases Revenue by Type (2016-2026)

9.2 South America POC Infectious Diseases Revenue by Application (2016-2026)

9.3 South America POC Infectious Diseases Market Size by Country

9.3.1 South America POC Infectious Diseases Revenue by Country (2016-2026)

9.3.2 Brazil POC Infectious Diseases Market Size and Forecast (2016-2026)

9.3.3 Argentina POC Infectious Diseases Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa POC Infectious Diseases Revenue by Type (2016-2026)

10.2 Middle East & Africa POC Infectious Diseases Revenue by Application (2016-2026)

10.3 Middle East & Africa POC Infectious Diseases Market Size by Country

10.3.1 Middle East & Africa POC Infectious Diseases Revenue by Country (2016-2026)

10.3.2 Turkey POC Infectious Diseases Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia POC Infectious Diseases Market Size and Forecast (2016-2026)

10.3.4 UAE POC Infectious Diseases Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global POC Infectious Diseases Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global POC Infectious Diseases Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market POC Infectious Diseases Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global POC Infectious Diseases Revenue (USD Million) by Region (2016-2021)

Table 5. Global POC Infectious Diseases Revenue Market Share by Region (2021-2026)

Table 6. Abbott Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Major Business

Table 8. Abbott POC Infectious Diseases Product and Solutions

Table 9. Abbott POC Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Meridian Bioscience Corporate Information, Head Office, and Major Competitors

Table 11. Meridian Bioscience Major Business

Table 12. Meridian Bioscience POC Infectious Diseases Product and Solutions

Table 13. Meridian Bioscience POC Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Orasure Technologies Corporate Information, Head Office, and Major Competitors

Table 15. Orasure Technologies Major Business

Table 16. Orasure Technologies POC Infectious Diseases Product and Solutions

Table 17. Orasure Technologies POC Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Trinity Biotech Corporate Information, Head Office, and Major Competitors

Table 19. Trinity Biotech Major Business

Table 20. Trinity Biotech POC Infectious Diseases Product and Solutions

Table 21. Trinity Biotech POC Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Beckman Coulter/ Danaher Corporate Information, Head Office, and Major Competitors

Table 23. Beckman Coulter/ Danaher Major Business

Table 24. Beckman Coulter/ Danaher POC Infectious Diseases Product and Solutions

Table 25. Beckman Coulter/ Danaher POC Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Becton Dickinson Corporate Information, Head Office, and Major Competitors

Table 27. Becton Dickinson Major Business

Table 28. Becton Dickinson POC Infectious Diseases Product and Solutions

Table 29. Becton Dickinson POC Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Biomerieux Corporate Information, Head Office, and Major Competitors

Table 31. Biomerieux Major Business

Table 32. Biomerieux POC Infectious Diseases Product and Solutions

Table 33. Biomerieux POC Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Bio-Rad Corporate Information, Head Office, and Major Competitors

Table 35. Bio-Rad Major Business

Table 36. Bio-Rad POC Infectious Diseases Product and Solutions

Table 37. Bio-Rad POC Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Cepheid Corporate Information, Head Office, and Major Competitors

Table 39. Cepheid Major Business

Table 40. Cepheid POC Infectious Diseases Product and Solutions

Table 41. Cepheid POC Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Diamedix Corporate Information, Head Office, and Major Competitors

Table 43. Diamedix Major Business

Table 44. Diamedix POC Infectious Diseases Product and Solutions

Table 45. Diamedix POC Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Diasorin Corporate Information, Head Office, and Major Competitors

Table 47. Diasorin Major Business

Table 48. Diasorin POC Infectious Diseases Product and Solutions

Table 49. Diasorin POC Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Eiken Chemical Corporate Information, Head Office, and Major Competitors

Table 51. Eiken Chemical Major Business

Table 52. Eiken Chemical POC Infectious Diseases Product and Solutions

Table 53. Eiken Chemical POC Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Enzo Biochem Corporate Information, Head Office, and Major Competitors

Table 55. Enzo Biochem Major Business

Table 56. Enzo Biochem POC Infectious Diseases Product and Solutions

Table 57. Enzo Biochem POC Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Global POC Infectious Diseases Revenue (USD Million) by Players (2019-2021)

Table 59. Global POC Infectious Diseases Revenue Share by Players (2019-2021)

Table 60. Breakdown of POC Infectious Diseases by Company Type (Tier 1, Tier 2 and Tier 3)

Table 61. POC Infectious Diseases Players Head Office, Products and Services Provided

Table 62. POC Infectious Diseases Mergers & Acquisitions in the Past Five Years

Table 63. POC Infectious Diseases New Entrants and Expansion Plans

Table 64. Global POC Infectious Diseases Revenue (USD Million) by Type (2016-2021)

Table 65. Global POC Infectious Diseases Revenue Share by Type (2016-2021)

Table 66. Global POC Infectious Diseases Revenue Forecast by Type (2021-2026)

Table 67. Global POC Infectious Diseases Revenue by Application (2016-2021)

Table 68. Global POC Infectious Diseases Revenue Forecast by Application (2021-2026)

Table 69. North America POC Infectious Diseases Revenue by Type (2016-2021) & (USD Million)

Table 70. North America POC Infectious Diseases Revenue by Type (2021-2026) & (USD Million)

Table 71. North America POC Infectious Diseases Revenue by Application (2016-2021) & (USD Million)

Table 72. North America POC Infectious Diseases Revenue by Application (2021-2026) & (USD Million)

Table 73. North America POC Infectious Diseases Revenue by Country (2016-2021) & (USD Million)

Table 74. North America POC Infectious Diseases Revenue by Country (2021-2026) & (USD Million)

Table 75. Europe POC Infectious Diseases Revenue by Type (2016-2021) & (USD Million)

Table 76. Europe POC Infectious Diseases Revenue by Type (2021-2026) & (USD Million)

Table 77. Europe POC Infectious Diseases Revenue by Application (2016-2021) & (USD Million)

Table 78. Europe POC Infectious Diseases Revenue by Application (2021-2026) & (USD Million)

Table 79. Europe POC Infectious Diseases Revenue by Country (2016-2021) & (USD Million)

Table 80. Europe POC Infectious Diseases Revenue by Country (2021-2026) & (USD Million)

Table 81. Asia-Pacific POC Infectious Diseases Revenue by Type (2016-2021) & (USD Million)

Table 82. Asia-Pacific POC Infectious Diseases Revenue by Type (2021-2026) & (USD Million)

Table 83. Asia-Pacific POC Infectious Diseases Revenue by Application (2016-2021) & (USD Million)

Table 84. Asia-Pacific POC Infectious Diseases Revenue by Application (2021-2026) & (USD Million)

Table 85. Asia-Pacific POC Infectious Diseases Revenue by Region (2016-2021) & (USD Million)

Table 86. Asia-Pacific POC Infectious Diseases Revenue by Region (2021-2026) & (USD Million)

Table 87. South America POC Infectious Diseases Revenue by Type (2016-2021) & (USD Million)

Table 88. South America POC Infectious Diseases Revenue by Type (2021-2026) & (USD Million)

Table 89. South America POC Infectious Diseases Revenue by Application (2016-2021) & (USD Million)

Table 90. South America POC Infectious Diseases Revenue by Application (2021-2026) & (USD Million)

Table 91. South America POC Infectious Diseases Revenue by Country (2016-2021) & (USD Million)

Table 92. South America POC Infectious Diseases Revenue by Country (2021-2026) & (USD Million)

Table 93. Middle East & Africa POC Infectious Diseases Revenue by Type (2016-2021) & (USD Million)

Table 94. Middle East & Africa POC Infectious Diseases Revenue by Type (2021-2026) & (USD Million)

Table 95. Middle East & Africa POC Infectious Diseases Revenue by Application (2016-2021) & (USD Million)

Table 96. Middle East & Africa POC Infectious Diseases Revenue by Application (2021-2026) & (USD Million)

Table 97. Middle East & Africa POC Infectious Diseases Revenue by Country (2016-2021) & (USD Million)

Table 98. Middle East & Africa POC Infectious Diseases Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. POC Infectious Diseases Picture

Figure 2. Global POC Infectious Diseases Revenue Market Share by Type in 2020

Figure 3. Flu

Figure 4. Adenovirus

Figure 5. Malaria

Figure 6. Streptococcal Bacteremia

Figure 7. Tuberculosis (TB)

Figure 8. Occult Blood

Figure 9. HIV

Figure 10. POC Infectious Diseases Revenue Market Share by Application in 2020

Figure 11. Hospital& Clinics Picture

Figure 12. Clinical Diagnostic Laboratories Picture

Figure 13. Homecare Settings Picture

Figure 14. Global POC Infectious Diseases Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 15. Global POC Infectious Diseases Revenue and Forecast (2016-2026) & (USD Million)

Figure 16. Global POC Infectious Diseases Revenue Market Share by Region (2016-2026)

Figure 17. Global POC Infectious Diseases Revenue Market Share by Region in 2020

Figure 18. North America POC Infectious Diseases Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Europe POC Infectious Diseases Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Asia-Pacific POC Infectious Diseases Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. South America POC Infectious Diseases Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Middle East and Africa POC Infectious Diseases Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. POC Infectious Diseases Market Drivers

Figure 24. POC Infectious Diseases Market Restraints

Figure 25. POC Infectious Diseases Market Trends

Figure 26. Abbott Recent Developments and Future Plans

Figure 27. Meridian Bioscience Recent Developments and Future Plans

Figure 28. Orasure Technologies Recent Developments and Future Plans

Figure 29. Trinity Biotech Recent Developments and Future Plans

Figure 30. Beckman Coulter/ Danaher Recent Developments and Future Plans

Figure 31. Becton Dickinson Recent Developments and Future Plans

Figure 32. Biomerieux Recent Developments and Future Plans

Figure 33. Bio-Rad Recent Developments and Future Plans

Figure 34. Cepheid Recent Developments and Future Plans

Figure 35. Diamedix Recent Developments and Future Plans

Figure 36. Diasorin Recent Developments and Future Plans

Figure 37. Eiken Chemical Recent Developments and Future Plans

Figure 38. Enzo Biochem Recent Developments and Future Plans

Figure 39. Global POC Infectious Diseases Revenue Share by Players in 2020

Figure 40. POC Infectious Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 41. Global Top 3 Players POC Infectious Diseases Revenue Market Share in 2020

Figure 42. Global Top 10 Players POC Infectious Diseases Revenue Market Share in 2020

Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 44. Global POC Infectious Diseases Revenue Share by Type in 2020

Figure 45. Global POC Infectious Diseases Market Share Forecast by Type (2021-2026)

Figure 46. Global POC Infectious Diseases Revenue Share by Application in 2020

Figure 47. Global POC Infectious Diseases Market Share Forecast by Application (2021-2026)

Figure 48. North America POC Infectious Diseases Sales Market Share by Type (2016-2026)

Figure 49. North America POC Infectious Diseases Sales Market Share by Application (2016-2026)

Figure 50. North America POC Infectious Diseases Revenue Market Share by Country (2016-2026)

Figure 51. United States POC Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Canada POC Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Mexico POC Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Europe POC Infectious Diseases Sales Market Share by Type (2016-2026)

Figure 55. Europe POC Infectious Diseases Sales Market Share by Application (2016-2026)

Figure 56. Europe POC Infectious Diseases Revenue Market Share by Country (2016-2026)

Figure 57. Germany POC Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. France POC Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. United Kingdom POC Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Russia POC Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Italy POC Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Asia-Pacific POC Infectious Diseases Sales Market Share by Type (2016-2026)

Figure 63. Asia-Pacific POC Infectious Diseases Sales Market Share by Application (2016-2026)

Figure 64. Asia-Pacific POC Infectious Diseases Revenue Market Share by Region (2016-2026)

Figure 65. China POC Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Japan POC Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. South Korea POC Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. India POC Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Southeast Asia POC Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Australia POC Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. South America POC Infectious Diseases Sales Market Share by Type (2016-2026)

Figure 72. South America POC Infectious Diseases Sales Market Share by Application (2016-2026)

Figure 73. South America POC Infectious Diseases Revenue Market Share by Country (2016-2026)

Figure 74. Brazil POC Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Argentina POC Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Middle East and Africa POC Infectious Diseases Sales Market Share by Type (2016-2026)

Figure 77. Middle East and Africa POC Infectious Diseases Sales Market Share by Application (2016-2026)

Figure 78. Middle East and Africa POC Infectious Diseases Revenue Market Share by Country (2016-2026)

Figure 79. Turkey POC Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Saudi Arabia POC Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. UAE POC Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Methodology

Figure 83. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz